Black Diamond Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -86 | -86 | -86 | |
EBITDA | -18,190 | -18,044 | -22,044 | -20,160 |
EBIT | -18,275 | -18,130 | -22,130 | -20,246 |
Net Income | -15,985 | -15,557 | -19,909 | -18,225 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,055 | -11,323 | -14,726 | -21,199 |
Cash | 36,437 | 23,425 | 32,811 | 25,422 |
Basic Shares | 56,607 | 56,507 | 55,155 | 51,808 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -437 | -3,238 | -2,217 | |
EBITDA | -78,781 | -86,023 | -92,320 | -126,667 |
EBIT | -86,460 | -95,558 | -128,884 | |
Net Income | -69,676 | -82,442 | -84,520 | -123,203 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -31,539 | 31,194 | ||
Free Cash Flow | -62,303 | -66,750 | -85,274 | -102,858 |
Cash | 36,437 | 56,221 | 34,315 | 65,799 |
Basic Shares | 55,028 | 43,954 | 36,325 | 36,189 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.28 |
2024-09-30 | -$0.27 |
2024-06-30 | -$0.36 |
2024-03-31 | -$0.35 |
